石家庄以岭药业股份有限公司关于实际控制人部分股份质押展期的公告

Group 1 - The core point of the announcement is that the actual controller of Shijiazhuang Yiling Pharmaceutical Co., Ltd., Wu Rui, has notified the company about the extension of the pledge on part of her shares [1] - The announcement details the basic situation of the shareholder's share pledge extension, indicating that Wu Rui's credit status is good and she has a strong repayment ability, thus the pledge risk is controllable [1] - The pledged shares will not lead to a change in the company's actual control, nor will it affect the company's production operations and governance [1] Group 2 - As of the announcement date, the cumulative situation of pledged shares held by the shareholder and their concerted actions is provided, indicating that the pledged shares are subject to restrictions due to being locked-up shares for executives [1] - In case of any risk of forced liquidation, Wu Rui will take measures such as additional pledges or early repurchase of the pledged shares to mitigate risks [1]